Neutroplast will attend Pharmapack 2022, which will take place on the 18th and 19th of May, at the Paris Expo. Like always, the event is an opportunity to make our permanent evolution known, in an environment aimed at the Western Europe pharmaceutical market. It will be a space to connect with our partners, but also to get to know those who just arrived in our industry.
This year, we will again be at the head of innovative solutions in pharmaceutical packaging. As such, we will take part in the Pharmapack Innovation Awards, where we will showcase our most recent concept in bio-packaging with monitoring technology and medication support.
These jars, which are being patented, are produced from biopolymers and are at a proof-of-concept phase. They are part of an initiative that seeks to promote plastic consumption circularity, by reducing new polymer production and lengthening their life cycle. Two raw materials were tested, with that in mind, one from polypropylene and eucalyptus and a second one from high-density polyethylene and mussels.
On the other hand, these solutions are integrated with our DOSEA solution, to monitor treatment adherence and efficacy validation. The bio-packaging with monitoring technology and medication support offers, therefore, several advantages, both for healthcare markets and for conducting large-scale clinical trials.
At Neutroplast, we pride ourselves on our technical acumen and cutting-edge industrial processes. Our team is passionate about what they do and is committed to providing the best possible experience for our customers. Our belief is that technology should be accessible to everyone and strive to make our products available at a price point that meets the needs of all consumers. These are the reasons why we cordially invite you to join us at the Paris Expo, where you will have access to the latest and greatest in our industry. Our team is looking forward to meeting you, so make sure to visit us!